You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

HYDRALAZINE HYDROCHLORIDE W Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Hydralazine Hydrochloride W patents expire, and what generic alternatives are available?

Hydralazine Hydrochloride W is a drug marketed by Ivax Pharms and is included in three NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE W is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDRALAZINE HYDROCHLORIDE W?
  • What are the global sales for HYDRALAZINE HYDROCHLORIDE W?
  • What is Average Wholesale Price for HYDRALAZINE HYDROCHLORIDE W?
Summary for HYDRALAZINE HYDROCHLORIDE W
US Patents:0
Applicants:1
NDAs:3
DailyMed Link:HYDRALAZINE HYDROCHLORIDE W at DailyMed
Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE W

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE W

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 088358-001 Apr 10, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ivax Pharms HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 088356-001 Apr 10, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ivax Pharms HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 088357-001 Apr 10, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.